姓名：费洪荣
硕士生导师
职称：教授
联系方式：15662099068，hrfei@sdfmu.edu.cn
研究方向：
1. 肿瘤分子生物学
2. 天然药物活性成分的提取分离及抗肿瘤活性
主要获奖情况（包括作为指导教师）：
1. 山东省高等学校科技技术奖，三等奖，第一位，2020年12月
2. 第八届科技创新大赛校赛，三等奖，指导教师，2022年
主持科研课题：
1. 国家自然科学基金青年基金，81703039，告达庭抑制DNA损伤修复与糖酵解途径增加乳腺癌放疗敏感性的机制研究，2018/01-2020/12，20万元，已结题，主持
2. 山东省自然科学基金面上项目，半枝莲碱A抑制DNA损伤修复和NF-κB通路增强乳腺癌放疗敏感性的机制研究，2023/01-2025/12，10万元，在研，主持
3.山东省中医药科技项目面上项目，半枝莲生物碱质量控制及其抑制乳腺癌细胞活性的分子机制研究，2021/03-2023/02，3万元，已结题，主持
近五年代表性论文（限第一作者和通讯作者）：
1. Niu, Chong; Li, Ruo-tong; Hao, Xiao-shan; Qi, Xiao; Wang, Feng-ze; Fei, Hong-rong. Scutebarbatine B Exerts Anti-Breast Cancer Activity by Inducing Cell Cycle Arrest and Apoptosis Through Multiple Pathways, Phytotherapy Research, 2025, 39(8): 3432-3449
2. Xiao-shan Hao; Pan-pan Feng; Yun-yun Zhang; Feng-ze Wang; Gui-ling Wang; Hong-rong Fei. Scutebarbatine A induces ROS-mediated DNA damage and apoptosis in breast cancer cells by modulating MAPK and EGFR/Akt signaling pathway, Chemico-Biological Interactions, 2023, 378: 1-13
3. Xiao Qi, Chong Niu · Zi-zheng Zhang, Meng-ru Chen, Feng-ze Wang, Hong-rong Fei. 6-Methoxydihydrosanguinarine Suppresses the Proliferation of Non small Cell Lung Cancer Cells through Elevation of ROS and Activation of IRE1/JNK Signaling. Cell Biochemistry and Biophysics, 2025, doi.org/10.1007/s12013-025-01850
4. Pan‐pan Feng; You‐kun Qi; Na Li; Hong‐rong Fei. Scutebarbatine A induces cytotoxicity in hepatocellular carcinoma via activation of the MAPK and ER stress signaling pathways, J Biochem Mol Toxicol., 2021, e22731
5. Yun-yun Zhang; Pan-pan Feng; Hong-fei Wang; Heng Zhang; Tao Liang; Xiao-shan Hao; Feng-ze Wang; Hong-rong Fei. Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells., Chemico-Biological Interactions, 2022, 365: 1-16
6. Zhao-Jun Li, Ya-Jun Hou, Gang-Ping Hao, Xiao-Xuan Pan, Hong-Rong Fei, Feng-Ze Wang. CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells. Journal of Cell Communication and Signaling, 2020, 14:377–387
